Condition: Acute Respiratory Failure · Critical Illness · Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic
Mechanically ventilated intensive care patients will be sampled for a small amount of exhaled breath condensate from the ventilator circuit and for venous blood. Proteomic analysis of the exhaled breath condensate will be performed using mass spectrometry and in the blood sample, corresponding changes in the DNA, RNA, proteins, and metabolites will be studied. Resulting profiles will be correlated with routinely monitored parameters in order to identify patterns corresponding to various pathologies in order to enable their early detection.
This description comes directly from the study's public registry record.
Emil Berta, MD PhD · +420585632111 · e.berta@upol.cz
Karel Axmann, MD · +420588445356 · karel.axmann@fnol.cz
Always discuss trial participation with your own doctor first.
| Institute of Molecular and Translational Medicine, Palacky University | Olomouc, Czechia | Recruiting |
| University Hospital Olomouc | Olomouc, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06189924